Almirall S.A.:企業の戦略・SWOT・財務分析

◆英語タイトル:Almirall S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4455
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Almirall S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Almirall S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Almirall S.A. (Almirall or ‘the company’) is involved in the manufacturing, and selling of proprietary drugs and licensed products. It also works in collaborations with various healthcare professionals, medical societies, and patient organisations such as The International Psoriasis Council (IPC), The European Academy of Dermatology and Venereology (EADV), The American Academy of Dermatology (AAD), The International League of Dermatological Societies (ILDS) and The Psoriasis from Gene to Clinic (Psoriasis G2C) for identifying new and innovative technologies and solutions in developing these products. The company is headquartered in Barcelona, Spain

Scope

- Detailed information on Almirall S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Almirall S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Almirall S.A. including a breakdown and examination of key business segments
- Intelligence on Almirall S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Almirall S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Almirall S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Almirall S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Almirall S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Almirall S.A.: Company Overview
Almirall S.A.: Overview and Key Facts
Almirall S.A.: Overview
Almirall S.A.: Key Facts
Almirall S.A.: Key Employees
Almirall S.A.: Key Employee Biographies
Almirall S.A.: Major Products and Services
Almirall S.A.: Company History
Almirall S.A.: Management Statement
Almirall S.A.: Locations and Subsidiaries
Almirall S.A.: Key Competitors
Almirall S.A.: Company Analysis
Almirall S.A.: Business Description
Almirall S.A.: SWOT Analysis
Almirall S.A.: SWOT Overview
Almirall S.A.: Strengths
Almirall S.A.: Weaknesses
Almirall S.A.: Opportunities
Almirall S.A.: Threats
Almirall S.A.: Corporate Financial Deals Activity
Almirall S.A.: Financial Deals Overview
Almirall S.A.: Targets and Partners
Almirall S.A.: Top Deals 2016 – 2020YTD*
Almirall S.A.: Advisors
Almirall S.A.: Top Legal Advisors
Almirall S.A.: Top Financial Advisors
Almirall S.A.: Mergers and Acquisitions
Almirall S.A.: Capital Raising
Almirall S.A.: Partnership
Almirall S.A.: Divestments
Almirall S.A.: Recent Developments
Almirall S.A.: News and Events Summary
Almirall S.A.: Contracts
Almirall S.A.: Corporate Governance
Almirall S.A.: Financial Performance
Almirall S.A.: Market Developments
Almirall S.A.: Red Flags/DistressSignals
Almirall S.A.: Regulatory and Legal Events
Almirall S.A.: Research & Development
Almirall S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Almirall S.A.: Key Facts
Table 2: Almirall S.A.: Key Employees
Table 3: Almirall S.A.: Company History
Table 4: Almirall S.A.: Locations and Subsidiaries
Table 5: Almirall S.A.: Key Competitors
Table 6: Almirall S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Almirall S.A.: M&A Activity by Geography (TTM*)
Table 8: Almirall S.A.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Almirall S.A.: M&A Average Deal Size - Value (US$m)
Table 10: Almirall S.A.: Targets and Partners
Table 11: Almirall S.A.: Top Deals 2016 - 2020YTD*
Table 12: Almirall S.A.: Legal Advisor Ranking by Value (US$m)
Table 13: Almirall S.A.: Financial Advisor Ranking by Value (US$m)
Table 14: Almirall S.A.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Almirall S.A.: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Almirall S.A.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 17: Almirall S.A.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 18: Almirall S.A.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Almirall S.A.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Almirall S.A.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 21: Almirall S.A.: Divestments by Geography (2016 - YTD*2020)
Table 22: Almirall S.A.: News and Events Summary
Table 23: Almirall S.A.: Contracts
Table 24: Almirall S.A.: Corporate Governance
Table 25: Almirall S.A.: Financial Performance
Table 26: Almirall S.A.: Market Developments
Table 27: Almirall S.A.: Red Flags/DistressSignals
Table 28: Almirall S.A.: Regulatory and Legal Events
Table 29: Almirall S.A.: Research & Development
Table 30: Almirall S.A.: Strategy and Operations

★海外企業調査レポート[Almirall S.A.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abbott Molecular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Molecular Inc (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical diagnostic company that provides molecular testing solutions. The company’s products include infectious disease products, oncology products, genetics products, automation products, molecular diagnostics …
  • Domino Printing Sciences plc:企業の戦略的SWOT分析
    Domino Printing Sciences plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Schmolz + Bickenbach AG:企業の戦略・SWOT・財務情報
    Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report Summary Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bush Industries Inc:企業の戦略・SWOT・財務情報
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Lafarge Malaysia Berhad (LAFMSIA):企業の財務・戦略的SWOT分析
    Summary Lafarge Malaysia Berhad (LMB), formerly Lafarge Malayan Cement Berhad is a construction company that manufactures and markets aggregates, ready-mixed concrete, cement, and related construction and building materials. The company offers cement products such as walcrete, rumah, phoenix, oil we …
  • Active Motif Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Genera Biosystems Ltd (GBI):製品パイプライン分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • Bausch & Lomb Inc:企業の戦略的SWOT分析
    Bausch & Lomb Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Jinchuan Group International Resources Co. Ltd:企業の戦略・SWOT・財務情報
    Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Jinchuan Group International Resources Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Circassia Group Plc (CIR):企業の財務・戦略的SWOT分析
    Circassia Group Plc (CIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • H&R GmbH & Co KGaA (2HR):企業の財務・戦略的SWOT分析
    H&R GmbH & Co KGaA (2HR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mondi Plc (MNDI):企業の戦略的SWOT分析
    Mondi Plc (MNDI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Medical Prognosis Institute AS (MPI)-医療機器分野:企業M&A・提携分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers DRP platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurpo …
  • American Greetings Corporation (AM):企業の戦略的SWOT分析
    American Greetings Corporation (AM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Enmax Corporation:電力:M&Aディール及び事業提携情報
    Summary ENMAX Corporation (ENMAX), a subsidiary of City of Calgary, is a vertically integrated energy utility. It generates, transmits and distributes electricity; supplies natural gas; and provides value-added services. Through its subsidiaries, the company undertakes deregulated electricity genera …
  • China Construction Bank Corp:企業の戦略・SWOT・財務情報
    China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report Summary China Construction Bank Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Takeda Pharmaceuticals USA Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company’s products include pioglitazone and glimepiride, lubiprostone, piogl …
  • athenahealth Inc (ATHN):製薬・医療:M&Aディール及び事業提携情報
    Summary athenahealth Inc (athenahealth) is a provider of cloud-based business services and mobile applications for medical groups and health system. The company offers network-enabled services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, popu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆